Michael Sorenson
B
From Conquer MG:

Conquer MG is excited to share that the FDA has approved yet another new MG treatment! 📣 RYSTIGGO® (rozanolixizumab-noli) by ucb_news is a monoclonal antibody therapy administered by subcutaneous injection. #MyastheniaGravis
07:53 PM - Jul 05, 2023
Avatar
0
0
1

 

{{ notificationModalContent }} {{ promptModalMessage }}